Reuters logo
3 years ago
BRIEF-Basilea Pharmaceutica says isavuconazole receives orphan drug designations in Europe for treatment of invasive mold infections
July 14, 2014 / 5:21 AM / 3 years ago

BRIEF-Basilea Pharmaceutica says isavuconazole receives orphan drug designations in Europe for treatment of invasive mold infections

1 Min Read

July 14 (Reuters) - Basilea Pharmaceutica AG : * Says isavuconazole receives orphan drug designations in Europe for treatment of invasive mold infections * Source text for Eikon [ID:nHUG6y9z1k ] * Further company coverage

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below